Okebo
NDC Package 69482-475-99
Package Information
Okebo is a medication used to treat a wide variety of bacterial infections, including those that cause acne. Marketed by Encore Dermatology Inc., this product is identified by NDC 69482-475 and is authorized under FDA application ANDA204234.
Identification & Billing
- RxCUI: 2045898 - Okebo 75 MG Oral Capsule
- RxCUI: 2045898 - doxycycline monohydrate 75 MG Oral Capsule [Okebo]
- RxCUI: 700408 - doxycycline monohydrate 75 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69482 - Encore Dermatology Inc.
- 69482-475 - Okebo
- 69482-475-99 - 100 CAPSULE in 1 BOTTLE
- 69482-475 - Okebo
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69482-475). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69482-475-99 identifies a specific commercial package of 100 capsule in 1 bottle of Okebo, labeled by Encore Dermatology Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Encore Dermatology Inc. on November 20, 2017. The current certification is valid through December 31, 2021.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Encore Dermatology Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69482047599. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.